All Stories

  1. Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome

    Article • Critical Reviews in Clinical Laboratory Sciences, September 2018, Taylor & Francis

    Mrs Laura T Pop, Dr Alina D Tanase, Andrei Colita, Angela Dascalescu

  2. Minimal residual disease in chronic lymphocytic leukemia: A consensus paper that presents the clinical impact of the presently available laboratory approaches

    Article • Critical Reviews in Clinical Laboratory Sciences, May 2018, Taylor & Francis

    Dr Alina D Tanase, Mrs Laura T Pop, KANZA ARIFEEN

  3. Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy

    Article • International Journal of Nanomedicine, February 2016, Dove Medical Press

    Dr Alina D Tanase, Dr Sorina Suarasan, Professor Anca Dana Buzoianu

  4. Small molecules against B-RAF (BRAF) Val600Glu (V600E) single mutation

    Article • International Journal of Nanomedicine, July 2015, Dove Medical Press

    Mrs Roxana M Cojocneanu Petric, Miss Mariana Chitic, Dr Alina D Tanase, Dr Mihai-Stefan Muresan